Harm reduction or women's rights? Debating access to emergency contraceptive pills in Canada and the United States

Studies in Family Planning

Volumn 38, Issue 4, 2007, Pages 253-267

  Wynn, L L ^a   Erdman, Joanna N ^b   Foster, Angel M ^c   Trussell, James ^d  

^a MACQUARIE UNIVERSITY   (Australia)

^b UNIVERSITY OF TORONTO   (Canada)

^c IBIS REPRODUCTIVE HEALTH   (United States)

^d PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG;

CONTRACEPTIVE USE; HEALTH RISK; HUMAN RIGHTS; REPRODUCTIVE HEALTH; WOMENS HEALTH;

ADOLESCENT; ADULT; ARTICLE; CANADA; COMPARATIVE STUDY; EMERGENCY CONTRACEPTION; ETHICS; FEMALE; HARM REDUCTION; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; MALE; UNITED STATES; UTILIZATION REVIEW; WOMEN'S HEALTH; WOMEN'S RIGHTS;

ADOLESCENT; ADULT; CANADA; CONTRACEPTION, POSTCOITAL; DRUGS, NON-PRESCRIPTION; FEMALE; HARM REDUCTION; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; UNITED STATES; WOMEN'S HEALTH; WOMEN'S RIGHTS;

CANADA; NORTH AMERICA; UNITED STATES;

EID: 36949014955     PISSN: 00393665     EISSN: 17284465     Source Type: Journal    
DOI: 10.1111/j.1728-4465.2007.00138.x     Document Type: Article

References (107)

1. Abortion Rights Coalition of Canada (ARCC). 2005. The Canadian Abortion Provider Shortage: Now and Tomorrow. Position Paper #5. Vancouver: ARCC. . Accessed 22 January 2007.
2. American Medical Association (AMA) Board of Trustees. 2006. "Report of the Board of Trustees 18-I-06." . Accessed 12 October 2007.
3. American Medical Association (AMA) House of Delegates. No date. H 120.947 "Preserving patients' ability to have legally valid prescriptions filled. "House of Delegates Resolutions, Sub. Res. 6, A-05. http://www.ama-assn.org/apps/pf_new/pf_online?f_n= resultLink&doc=policyfiles/HnE/H-120.947.HTM&s_t= H+120.947&catg=AMA/HnE&catg=AMA/BnGnC&catg=AMADIR&nth= 1&&st_p=0&nth=1&. Accessed 23 January 2007.
4. Association of Reproductive Health Professionals (ARHP). 2003. "EC OTC sign-on letter to the FDA." 4 December 2003. . Accessed 15 May 2006.
5. Bossom, E. 2006. "Contraception or deception?" Concerned Women for America. . Accessed 22 January 2007.
6. Campaign Life Coalition B.C. (CLCBC). 2005. "Pharmacists rightly concerned about women's health and Plan B." December 2005 Newsletter. . Accessed 12 October 2007.
7. Canada Gazette Part II. 2005. "Regulatory impact analysis statement," SOR/2005-105, 139(9): 857-871.
8. Canadian Medical Association Journal (CMAJ). 2005. "Emergency contraception moves behind the counter." Editorial. Canadian Medical Association Journal 172(7): 845.
9. Canadian Pharmacists Association (CPA). 2004. Letter to the Therapeutic Products Directorate, Health Canada (5 August 2004).
10. Canadian Pharmacists Association (CPA). 2005a. "Screening form for emergency contraceptive pills." . Accessed 13 July 2006.
11. Canadian Pharmacists Association (CPA). 2005b. "Emergency contraception questions and answers for pharmacists." . Accessed 13 July 2006.
12. Canadian Pharmacists Association (CPA). 2005c. "Letters to governments regarding ECP cost concerns." 26 April. . Accessed 23 January 2007.
13. Canadian Physicians for Life (CPL). 2004. "Canadian physicians group warns of dangers of 'morning after pill.'" Press release. 20 May. . Accessed 12 October 2007.
14. Canadian Physicians for Life (CPL). 2005. "Health Canada's evasive response about 'morning after pill'concerns physicians." Press release. 12 April. . Accessed 22 January 2007.
15. Canadian Physicians for Life (CPL). 2007. "Morning after pill." . Accessed 22 January 2007.
16. Canadian Women's Health Network (CWHN). 2003. Letter to the Therapeutic Products Directorate, Health Canada (12 July 2003) "Re: The Proposal for an amendment to the Food and Drug Regulations-Schedule 1272 (Deletion of levonorgestrel, when indicated for use as an emergency contraceptive, from Schedule F of the Food and Drug Regulations)." . Accessed 12 October 2007.
17. Canadian Women's Health Network (CWHN). 2004. Letter to the Therapeutic Products Directorate, Health Canada (23 July 2004).
18. Cantor, Julie and Ken Baum. 2004. "The limits of conscientious objection-May pharmacists refuse to fill prescriptions for emergency contraception?" New England Journal of Medicine 351(19): 2,008-2,012.
19. Card, Robert F. 2007. "Conscientious objection and emergency contraception." The American Journal of Bioethics 7(6): 8-14.
20. Catholics for a Free Choice. 2002. "Student bodies: Reproductive health care at Catholic universities." . Accessed 19 July 2006.
21. Catholics for a Free Choice. 2006. "Complying with the law?How Catholic hospitals respond to state laws mandating the provision of emergency contraception to sexual assault victims." A study by Ibis Reproductive Health for Catholics for a Free Choice. . Accessed 19 July 2006.
22. Center for Reproductive Rights. 2006. "Depositions indicate Bush Administration exerted political influence on FDA during Plan B review process." . Accessed 9 October 2006.
23. Charo, R. Alta. 2005. "The celestial fire of conscience-Refusing to deliver medical care." New England Journal of Medicine 352(24): 2,471-2,473.
24. Chief Medical Officer (CMO) (Ontario). 2004. Letter to the Therapeutic Products Directorate, Health Canada (29 July 2004).
25. Childbirth by Choice Trust. 2003. "Abortion in Canada today: The situation province-by-province." Toronto: Childbirth By Choice Trust.
26. College of Pharmacists of British Columbia (CPBC). No date. Code of Ethics. . Accessed 23 January 2007.
27. Cook, Rebecca J., Bernard M. Dickens, and Joanna N. Erdman. 2006. "Emergency contraception, abortion and evidence-based law." International Journal of Gynecology & Obstetrics 93(2): 191-197.
28. Crawford, Lester. 2005. "FDA takes action on Plan B: Statement by FDA Commissioner Lester M. Crawford." . Accessed 20 August 2007.
29. Croxatto, Horacio B. 2007. "Postovulatory effects of levonorgestrel in emergency contraception." Contraception 75(5): 402.
30. Croxatto, Horacio B., Maria E. Ortiz, and Andres L. Müller. 2003. "Mechanisms of action of emergency contraception." Steroids 68(10-13): 1,095-1,098.
31. Dailard, Cynthia and ChinuéTurner Richardson. 2005. "Teenagers' access to confidential reproductive health services." The Guttmacher Report on Public Policy. New York: The Guttmacher Institute. Pp. 6-11.
32. Davidoff, Frank and James Trussell. 2006. "Plan B and the politics of doubt." Journal of the American Medical Association 296(14): 1,775-1,778.
33. Dickens, Bernard M. and Rebecca J. Cook. 2000. "The scope and limits of conscientious objection." International Journal of Gynecology & Obstetrics 71(1): 71-77.
34. Dunn, Sheila and Edith Guilbert. 2003. "SOGC clinical practice guidelines: Emergency contraception." Journal of Obstetrics and Gynaecology Canada 25(8): 673-679.
35. Eggertson, Laura. 2006. "Ontario pharmacists drop Plan B screening form." Canadian Medical Association Journal 174(2): 149-150.
36. Eggertson, Laura and Barbara Sibbald. 2005. "Privacy issues raised over Plan B: Women asked for names, addresses, sexual history." Canadian Medical Association Journal 173(12): 1,435-1,436.
37. Erdman, Joanna N. and Rebecca J. Cook. 2006. "Protecting fairness in women's health: The case of emergency contraception." In Just Medicare: What's In, What's Out, How We Decide. Ed. C. Flood. Toronto: University of Toronto Press. Pp. 137-167.
38. Fenton, Elizabeth and Loren Lomasky. 2005. "Dispensing with liberty: Conscientious refusal and the 'morning-after pill.'" Journal of Medicine and Philosophy 30(6): 579-592.
39. Foster, Angel M., Jane van Dis, and Jody Steinauer. 2003. "Educational and legislative initiatives affecting residency training in abortion." Journal of the American Medical Association 290(13): 1,777-1,778.
40. Galson, Steven. 2004. Letter to Joseph Carrado, Barr Research. . Accessed 20 August 2007.
41. Gee, Rebekah E. 2006. "Plan B, reproductive rights, and physician activism." New England Journal of Medicine 355(1): 4-5.
42. Glasier, Anna, Karen Fairhurst, Sally Wyke, et al. 2004. "Advanced provision of emergency contraception does not reduce abortion rates." Contraception 69(5): 361-366.
43. Gold, Melanie A., Jennifer E. Wolford, Kym A. Smith, and Andrew M. Parker. 2004. "The effects of advance provision of emergency contraception on adolescent women's sexual and contraceptive behaviors." Journal of Pediatric and Adolescent Gynecology 17(2): 87-96.
44. Gold, Rachel Benson. 2005. "The implications of defining when a woman is pregnant." The Guttmacher Report on Public Policy. . Accessed 20 January 2006.
45. Government of Canada, Minister Responsible for Women's Affairs (Ontario). 2004. Letter to the Therapeutic Products Directorate, Health Canada (July 2004). Letter on file with author.
46. Grimes, David. 2004. "Emergency contraception: Politics trumps science at the U.S. Food and Drug Administration." Obstetrics & Gynecology 104(2): 220-221.
47. Harper, Cynthia C., Monica Cheong, Corinne H. Rocca, Philip D. Darney, and Tina R. Raine. 2005a. "The effect of increased access to emergency contraception among young adolescents." Obstetrics & Gynecology 106(3): 483-491.
48. Harper, Cynthia C., Jillian T. Henderson, and Philip D. Darney. 2005b. "Abortion in the United States." Annual Review of Public Health 26: 501-512.
49. Harris, John. 2003. "Stem cells, sex and procreation." Cambridge Quarterly of Healthcare Ethics 12(4): 335-372.
50. Harrison, Teresa. 2005. "Availability of emergency contraception: A survey of hospital emergency department staff." Annals of Emergency Medicine 46(2): 105-110.
51. Hughes, Edward C. (ed.). 1972. Obstetric-Gynecologic Terminology. Philadelphia: F.A. Davis Company.
52. International Federation of Gynecology and Obstetrics, Committee for the Ethical Aspects of Human Reproduction and Women's Health. 2006. "Ethical guidelines on conscientious objection." Reproductive Health Matters 14(27): 148-149.
53. Johnson, Karen C., Lisa M. Klesges, Grant W. Somes, Mace C. Coday, and Margaret DeBon. 2004. "Access of over-the-counter nicotine replacement therapy products to minors." Archives of Pediatric & Adolescent Medicine 158(3): 212-216.
54. Jones, Rachel K. and Heather Boonstra. 2004. "Confidential reproductive health services for minors: The potential impact of mandated parental involvement for contraception." Perspectives on Sexual and Reproductive Health 36(5): 182-191.
55. Kaiser Network. 2006a. "Kaiser daily women's health policy report highlights issues in various states." Daily report, 16 March. . Accessed 22 January 2007.
56. Kaiser Network. 2006b. "Wal-Mart to stock EC Plan B at all pharmacies nationwide; Conn. health plans will not cover pharmacies not carrying EC, AG says." Daily report, 6 March. . Accessed 22 January 2007.
57. Kaufman, Marc. 2005. "FDA official quits over delay on Plan B: Women's health chief says commissioner's decision on contraceptive was political." The Washington Post 1 September: A08.
58. Kaufman, Marc. 2006. "Medical editors fired in Plan B dispute." The Washington Post 27 February: A07.
59. Kerr, Kathleen. 2006. "FDA faces more questions on Plan B. "Long Island Newsday. 24 April. . Accessed 15 May 2006.
60. Kirkey, Sharon. 2006. "Medical journal fires editor who alleged censorship: Dispute involves story on morning-after pill, prying pharmacists." The Ottawa Citizen 25 February.
61. Legislative Assembly of British Columbia. 2001a. "Votes and Proceedings of the Legislative Assembly of British Columbia." 2001 Legislative Session: 5th Session, 36th Parliament. Motion by the Honourable J. MacPhail. . Accessed 12 October 2007.
62. Legislative Assembly of British Columbia. 2001b. "Official Report of Debates of the Legislative Assembly of British Columbia." 28 March. Afternoon Sitting, Volume 22, Number 13, p. 17544. . Accessed 12 October 2007.
63. Lynd, Larry D., Jeffrey Taylor, Roy Dobson, and Donald J. Wilson. 2005. "Prescription to over-the-counter deregulation in Canada: Are we ready for it, or do we need to be?" Canadian Medical Association Journal 173(7): 775.
64. McLean-Morris, J. and G. van Wagenen. 1973. "Interception: The use of postovulatory estrogens to prevent implantation." American Journal of Obstetrics & Gynecology 115(1 January): 101-106.
65. Melbye, Mads, Jan Wohlfahrt, Jørgen H. Olsen, et al. 1997. "Induced abortion and the risk of breast cancer." New England Journal of Medicine 336(2): 81-85.
66. MergerWatch. 2005. "Health care providers." . Accessed 22 January 2007.
67. Müller, Andres L., C.M. Llados, and Horacio B. Croxatto. 2003. "Post-coital treatment with levonorgestrel does not disrupt postfertilization events in the rat." Contraception 67(6): 415-419.
68. Murray, George. 2006. "Privacy issues and Plan B: The Canadian Pharmacists Association responds." Canadian Medical Association Journal 174(1): 64-65.
69. Novikova Natalia, Edith Weisberg, Frank Z. Stanczyk, Horacio B. Croxatto, and Ian S. Fraser. 2007. "Effectiveness of levonorgestrel emergency contraception given before or after ovulation-A pilot study." Contraception 75(2): 112-118.
70. Ontario College of Pharmacists. 2006. "Code of ethics." . Accessed 23 January 2007.
71. Ontario Women's Health Council (OWHC). 2004. Letter to the Therapeutic Products Directorate, Health Canada (24 July 2004).
72. Ortiz, M.E., R.E. Ortiz, M.A. Fuentes, V.H. Parraguez, and H.B. Croxatto. 2004. "Postcoital administration of levonorgestrel does not interfere with post-fertilization events in the new-world monkey Cebus apella." Human Reproduction 19(6): 1,352-1,356.
73. Patel, A., A. Weber, H. Piotrowskin, and D. Patel. 2006. "A national survey of emergency room provision of emergency contraception to sexual assault victims." Contraception 74(2): 183.
74. Peterson, R.G. 2003. Re: Amendment to the Food and Drug Regulations - Schedule 1272 (Deletion of levonorgestrel, when indicated for use as an emergency contraceptive, from Schedule F of the Food and Drug Regulations). Letter from Health Canada, Therapeutic Products Directorate, 16 June.
75. Piaggio, Gilda, Helena von Hertzen, David A. Grimes, and Paul F.A. Van Look. 1999. "Timing of emergency contraception with levo-norgestrel or the Yuzpe regimen." Lancet 353(9,154): 721.
76. Polis, Chelsea B., Kate Schaffer, Kelly Blanchard, Anna Glasier, Cynthia C. Harper, and David A. Grimes. 2007. "Advance provision of emergency contraception for pregnancy prevention (full review)." Cochrane Database of Systematic Reviews 18(2): CD005497.
77. Poston, Jeff. 2003. Executive Director, Canadian Pharmacists Association, letter to Karen Ash, Health Canada, 16 July (on file with author).
78. Protection of Conscience Project (PCP). 2006. . Accessed 24 January 2007.
79. Pruitt, Sandi L. and Patricia Dolan Mullen. 2005. "Contraception or abortion?Inaccurate descriptions of emergency contraception in newspaper articles, 1992-2002." Contraception 71(1): 14-21.
80. Raine, Tina R., Cynthia C. Harper, Corinne H. Rocca, Richard Fischer, Nancy Padian, Jeffrey D. Klausner, and Philip D. Darney. 2005. "Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: A randomized controlled trial." Journal of the American Medical Association 293(1): 54-62.
81. Raymond, Elizabeth G., James Trussell, and Chelsea B. Polis. 2007. "Population effect of increased access to emergency contraceptive pills: A systematic review." Obstetrics & Gynecology 109(1): 181-188.
82. Richardson, ChinuéTurner and Elizabeth Nash. 2006. "Misinformed consent: The medical accuracy of state-developed abortion counseling materials." Guttmacher Policy Review 9(4): 6-11.
83. Smugar, Steve S., Bernadette J. Spina, and Jon F. Merz. 2000. "Informed consent for emergency contraception: Variability in hospital care of rape victims." American Journal of Public Health 90(9): 1,372-1,376.
84. Society of Obstetricians and Gynaecologists of Canada. 2005. "Pioneers in the struggle to provide emergency contraception access to Canadian women."
85. Stanford, Joseph B. 1999. "Sex, naturally." First Things: The Journal of Religion, Culture, and Public Life 97(11): 28-33.
86. Todkill, Anne Marie. 2006. "CMAJ responds." Canadian Medical Association Journal 174(1): 65.
87. Toronto Public Health. 2004. Letter to the Therapeutic Products Directorate, Health Canada (26 July 2004).
88. Trussell, James and Beth Jordan. 2006. "Mechanism of action of emergency contraceptive pills." Contraception 74(2): 87-89.
89. Trussell, James and Elizabeth G. Raymond. 2006. "How do we prevent unintended pregnancy? Let us count the ways." Lancet 368(9,549): 1,747-1,748.
90. Trussell, James and Tara Shochet. 2003. "Cost-effectiveness of emergency contraceptive pills in the public sector in the USA." Expert Review of Pharmacoeconomics and Outcomes Research 3(4): 433-440.
91. Trussell, James, Joseph A. Leveque, Jacqueline D. Koenig, et al. 1995. "The economic value of contraception: A comparison of 15 methods." American Journal of Public Health 85(4): 494-503.
92. Trussell, James, Charlotte Ellertson, Felicia Stewart, Elizabeth G. Raymond, and Tara Shochet. 2004. "The role of emergency contraception." American Journal of Obstetrics & Gynecology 190(Supplement 4): S30-S38.
93. Trussell, James, Jacqueline Koenig, Charlotte Ellertson, and Felicia Stewart. 1997a. "Preventing unintended pregnancy: The cost-effectiveness of three methods of emergency contraception." American Journal of Public Health 87(6): 932-937.
94. Trussell, James, Jacqueline Koenig, Felicia Stewart, and Jacqueline E. Darroch. 1997b. "Medical care cost savings from adolescent contraceptive use." Family Planning Perspectives 29(6): 248-255, 295.
95. Union of Concerned Scientists. 2006a. "Scientific integrity at risk: The Food and Drug Administration." . Accessed 12 October 2007.
96. Union of Concerned Scientists. 2006b. "UCS Food and Drug Administration survey: Selected excerpts from essay responses." . Accessed 12 October 2007.
97. United States Department of Health and Human Services (USDHHS). 1983. OPRR Reports: Protection of Human Subjects. Code of Federal Regulations 45CFR 46, 8 March.
98. United States Department of Health and Human Services (USDHHS). 2005. "Drug approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product." [Docket No. 2005N-0345]. . Accessed 20 August 2007.
99. United States Department of Justice (USDOJ). 2004. A National Protocol for Sexual Assault Medical Forensic Examinations: Adults/Adolescents. Washington, DC: USDOJ Office on Violence Against Women. . Accessed 19 July 2006.
100. United States Food and Drug Administration (USFDA). 2003. "Joint meeting of the Reproductive Health Drugs and Nonprescription Drugs Advisory Committees, Dec. 16, 2003." . Accessed 15 May 2006.
101. United States Food and Drug Administration (USFDA). 2006. "FDA approves over-the-counter access for Plan B for women 18 and older: Prescription remains for those 17 and under." Press release, 24 August. . Accessed 22 January 2007.
102. United States Government Accountability Office. 2005. "Food and Drug Administration decision process to deny initial application for over-the-counter marketing of emergency contraceptive drug Plan B was unusual." . Accessed 17 July 2006.
103. Women's Health Clinic (WHC). 2003. Letter to the Therapeutic Products Directorate, Health Canada (18 July 2003).
104. Wood, Alistair, Jeffrey M. Drazen, and Michael F. Green. 2005. "A sad day for science at the FDA." New England Journal of Medicine 353(12): 1197-1199.
105. Wood, Susan F. 2005. "Women's health and the FDA." New England Journal of Medicine 353(16): 1,650-1,651.
106. Wynn, L.L. and James Trussell. 2006a. "The social life of emergency contraception in the United States: Disciplining pharmaceutical use, disciplining sexuality, and constructing zygotic bodies." Medical Anthropology Quarterly 20(3): 297-320.
107. Wynn, L.L. and James Trussell. 2006b. "Images of American sexuality in debates over nonprescription access to emergency contraceptive pills." Obstetrics & Gynecology 108(5): 1,272-1,276.